IP Verse

Biogen patent opposition analysis

Get complete Patent Opposition Report for Biogen

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Biogen

Explore patent oppositions filed by Biogen against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3403646Liquid Pharmaceutical CompositionFRESENIUS KABI DEUTSCHLANDOct 5, 2022
EP3145488Liquid Pharmaceutical CompositionARES TRADINGJul 22, 2020
EP3212667Pharmaceutical Anti-Tnf-Alpha Antibody FormulationRICHTER GEDEON NYRTJun 19, 2019
EP3148510Liquid Pharmaceutical CompositionARES TRADINGMar 26, 2019

Latest patents of Biogen opposed by its competitors

Explore Biogen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2645106Oct 2, 2024Methods And Products For Evaluating An Immune Response To A Therapeutic Agent2
EP3036320Apr 3, 2024Control Of Protein Glycosylation By Culture Medium Supplementation And Cell Culture Process Parameters1
EP2956477Jan 24, 2024Optimized Factor Viii Gene1
EP3999643Nov 22, 2023Methods Of Treating Or Preventing Spinal Muscular Atrophy5
EP2701778Oct 18, 2023A Limiter For A Dispensing Device4
EP2972238Apr 26, 2023Use Of Raman Spectroscopy To Monitor Culture Medium2
EP3339865Dec 14, 2022Assay For Jc Virus Antibodies1
EP3575792Nov 30, 2022Method Of Assessing Risk Of Pml2
EP2653873Aug 24, 2022Compositions And Uses For Treating Multiple Sclerosis28
EP3122869Aug 10, 2022Methods For Overcoming Glutamine Deprivation During Mammalian Cell Culture1

Top competitors of Biogen